Chemistry, cytotoxicity and antileishmanial activity of the essential oil from Piper auritum

Memorias do Instituto Oswaldo Cruz

Volumn 105, Issue 2, 2010, Pages 168-173

  Monzote, Lianet ^a   García, Marley ^a   Montalvo, Ana Margarita ^a   Scull, Ramón ^b   Miranda, Migdalia ^b  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b INSTITUTO DE FARMACIA Y ALIMENTOS   (Cuba)

Author keywords

Essential oil; Leishmania; Piper auritum

Indexed keywords

LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIA MEXICANA; MUS; PIPER AURITUM; PIPERACEAE;

EID: 77951902633     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762010000200010     Document Type: Article

References (36)

1. Andrade SF, da Silva FAA, de O'Resende D, Silva ML, Cunha WR, Nanayakkara NP, Bastos JK 2008. Antileishmanial, antimalarial and antimicrobial activities of the extract and isolated compounds from Austroplenckia populnea (Celastraceae). Z Naturforsch C 63: 497-502.
2. Antony JP, Fyfe L, Smith H 2005. Plant active components a resource for antiparasitic agents? Trends Parasitol 21: 462-468.
3. Bailey MS, Lockwood DNJ 2007. Cutaneous leishmaniasis. Clin Dermatol 25: 203-211.
4. Bakkali F, Averbeck S, Averbeck D, Idaomar M 2008. Biological effects of essential oils a review. Food Chem Toxicol 46: 446-475.
5. Berger WC 1983. Piper auritum. In DH Janzen, Natural history of Costa Rica, University of Chicago Press, Chicago, p. 304-305.
6. Bodley AL, McGarry MW, Shapiro TA 1995. Drug cytotoxicity assay for African trypanosomes and Leishmania species. J Infect Dis 172: 1157-1159.
7. Brenzan MA, Nakamura CV, Dias Filho, BP, Ueda-Nakamura T, Young MCM, Cortez DAG 2007. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis. Parasitol Res 101: 715-722.
8. Caio TSE, Lima MD, Kaplan MAC, Nazareth MM, Rossi-Bergmann B 1999. Selective effect of 2',6'-dihydroxy-4'methoxychalcone isolated from Piper aduncum on Leishmania amazonensis. Antimicrob Agents Chemother 43: 1234-1241.
9. Callahan HL, Portal AC, Devereaux R, Grogl M 1997. An anexic amastigote system for drug screening. Antimicrob Agents Chemother 41: 818-822.
10. Croft SL, Snowdon D, Yardley V 1996. The activities of four anticancer alkyllysophospholipids against L. donovani, Trypanosoma cruzi and Trypanosoma brucei. J Antimicrob Chemother 38: 1041-1047.
11. Croft SL, Yardley V, Kendrick H 2002. Drug sensitivity of Leishmania species: some unresolved problems. Trans R Soc Trop Med Hyg 96: 127-129.
12. Cuba Ministerio de Salud Pública 1992. Norma Ramal SP 309. Medicamentos de origen vegetal: droga cruda. Métodos de ensayos, MINSAP, La Habana, 16-29 pp.
13. Davies CR, Kaye P, Croft SL, Sundar S 2003. Leishmaniasis: new approach to disease control. Br Med J 15: 377-382.
14. Desjeux P 2001. The increased in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95: 239-243.
15. Ephros M, Bitnun A, Shaked P, Walkman E, Zilberstein D 1999. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes. Antimicrob Agent Chemother 43: 278-282.
16. Espuelas S, Legrand P, Loiseau PM, Bories C, Barratt G, Irache JM 2000. In vitro reversion of amphotericin B resistance in Leishmania donovani by poloxamer 188. Antimicrob Agents Chemother 44: 2190-2192.
17. Flores N, Cabrera G, Jiménez IA, Pinero J, Jiménez A, Bourdy G, Cortes-Selva F, Bazzocchi IL 2007. Leishmanicidal constituents from the leaves of Piper rusbyi. Planta Med 73: 206-211.
18. García A, Leyva M, Martínez JR, Stashenko EE 2007. Determinación de la composición química y actividad antioxidante in vitro del aceite esencial de Piper auritum Kunth (Piperaceae) difundida en la costa colombiana. Scientia Tech 33: 439-442.
19. Garnier T, Croft SL 2002. Topical treatment for cutaneous leishmaniasis. Curr Opin Invest Drugs 3: 538-544.
20. Guerin PJ, Olliaro P, Sundar S, Boelvaert M, Croft SL, Desjeux P 2002. Visceral leishmaniasis: current status of control, diagnosis and treatment and proposed research and development agenda. Lancet Infect Dis 2: 494-501.
21. Gupta MP, Arjas TD, Williams NH, Bos R, Tattje DHE 1985. Safrole, the main component of the essential oil from Piper auritum Panamá. J Nat Prod 48: 330-336.
22. Hernández L, Rodríguez M, García D, Pino J 2003. Actividad antidermatofítica in vitro de aceites esenciales. Available from: http://scielo.sld. cu/scielo.php?script=sci_arttext&pid=S1028-47962003000200004&lng=es&nrm=iso&tlng=es.
23. Joly LG 1981. Feeding and trapping fish with Piper auritum. Economic Bot 35: 383-390.
24. Kamdem DP, Gage DA 1995. Chemical composition of essential oil from the root bark of Sassafras albidum. Planta Med 61: 574-575.
25. Monzote L, Montalvo AM, Almanonni S, Scull R, Miranda M, Abreu J 2006. Activity of the essential oil from Chenopodium ambrosioides grown in Cuba against Leishmania amazonensis. Chemother 52: 130-136.
26. Navarro MC, Montilla MP, Cabo MM, Galisteo M, Cáceres A, Morales C, Berger I 2003. Antibacterial, antiprotozoal and antioxidant activity of five plants used in Izabal for infectious diseases. Phytother Res 17: 325-329.
27. Oliveira VCS, Moura DMS, Lopes JAD, de Andrade PP, da Silva NH, Figueiredo RCBQ 2009. Effects of essential oils from Cymbopogon citratus (DC) Stapf., Lippia sidoides Cham., and Ocimum gratissimum L. on growth and ultrastructure of Leishmania chagasi promastigotes. Parasitol Res 104: 1053-1059.
28. Rosa MSS, Mendonça-Filho RR, Bizzo HR, Rodrigues IA, Soares RMA, Souto-Padrón T, Alviano CS, Lopes AHCS 2003. Antileishmanial activity of a linalool-rich essential oil from Croton cajucara. Antimicrob Agents Chemother 47: 1895-1901.
29. Santos AO, Ueda-Nakamura T, Dias BP, Veiga VF, Pinto AC, Nakamura CV 2008. Effect of Brazilian copaiba oils on Leishmania amazonensis. J Ethnopharmacol 120: 204-208.
30. Sarkar A, Sen R, Saha P, Ganguly S, Mandal G, Chatterjee M 2008. An ethanolic extract of leaves of Piper betle (Paan) Linn mediates its antileishmanial activity via apoptosis. Parasitol Res 102: 1249-1255.
31. Simić A, Soković MD, Ristić M, Grujić-Jovanović S, Vukojević J, Marin PD 2004. The chemical composition of some Lauraceae essential oils and their antifungal activities. Phytother Res 18: 713-717.
32. Sladowski D, Steer SJ, Clothier RH, Balls M 1993. An improve MTT assay. J Immunol Methods 157: 203-207.
33. Tiuman TS, Ueda-Nakamura T, Cortez DAG, Dias Filho BP, MorgadoDíaz JA, de Souza W, Nakamura CV 2005. Antileishmanial activity of parthenolide, a sesquiterpene lactone isolated from Tanacetum parthenium. Antimicrob Agent Chemother 49: 176-182.
34. Ueda-Nakamura T, Mendonça-Filho RR, Morgado-Díaz JA, Maza PK, Dias Filho BP, Cortez DAG, Alviano DS, Rosa MSS, Lopes AHCS, Alviano CS, Nakamura CV 2006. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum. Parasitol Int 55: 99-105.
35. Vizoso A, García A, Ramos A 1999. Ausencia de potencial genotóxico in vitro e in vivo de un extracto fluido de Piper auritum H.K.B. Rev Cub Plant Med 3: 57-64.
36. Yardley V, Croft SL, De Doncker S, Dujardin JC, Koirala S, Rijal S, Miranda C, Llanos-Cuentas A, Chappuis F 2005. The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine. Am J Trop Med Hyg 73: 272-275.